June 24, 2015
Blue Cross and Blue Shield of Louisiana accused Boehringer Ingelheim Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. on Tuesday in Connecticut federal court of violating antitrust laws through a pay-for-delay deal that they say inflated the price of a stroke medication.